Loading clinical trials...
Loading clinical trials...
Next-generation sequencing (NGS), and in particular whole exome sequencing (WES) or genome sequencing (WGS), has enabled a significant technical advance that has considerably improved genetic diagnost...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Centre Hospitalier Universitaire de Nice
NCT05554835 · Mitochondrial Diseases, Kearns-Sayre Syndrome, and more
NCT04802707 · Mitochondrial Diseases, Mitochondrial Encephalomyopathy, and more
NCT06573866 · Parkinson Disease, Hereditary Spastic Paraparesis, and more
NCT04920812 · Mitochondrial Diseases
NCT06504433 · Mitochondrial Diseases, Neurological Diseases or Conditions, and more
CHU de NIce
Nice, Alpes-maritimes
CHU de Montpellier
Montpellier
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions